Non-Center, Diabetic Macular Edema, Phacoemulsification
Conditions
Brief summary
This study aims to evaluate the progression of non-center-involving diabetic macular edema in the early postoperative period following phacoemulsification.
Detailed description
Diabetic patients have been reported to have a higher prevalence of cataract and develop it at an earlier age compared with nondiabetic individuals. According to recent population-based studies, diabetic macular edema (DME) is the most common cause of vision loss, with the incidence of non-center-involving DME (NCIDME) being higher than that of center-involving DME (CIDME). The prevalence of NCIDME in an urban south Indian population is 10.8%.
Interventions
OTHERColoured photography
Coloured photography will be performed preoperatively and at 3 and 6 months postoperatively.
Fluorescein angiography will be performed preoperatively and at 3 and 6 months postoperatively. The following features will be recorded on each angiography:
OTHEROptical coherence tomography
Optical coherence tomography (OCT) scanning will be performed using the optical coherence tomography scanner OCT (OPTOVUE OCT). OCT will be performed preoperatively and at 3 and 6 months postoperatively.
Sponsors
Ain Shams University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥18 years. * Both sexes. * Patients with Grade I - Grade II nuclear cataract and non-center-involving diabetic macular edema (NCIDME).
Exclusion criteria
* Traumatic cataract. * Severe Non-Proliferative/ Proliferative Diabetic Retinopathy. * Marked Asymmetry of retinopathy between both eyes. * Mature senile cataract or severe lens opacity. * Potentiality to have Phacotrabeculectomy surgery. * Complications during or after the surgery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Best Corrected Visual Acuity | 6 months post-procedure | Best Corrected Visual Acuity (BCVA) will be recorded. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intra ocular pressure | 6 months post-procedure | Intra ocular pressure (IOP) will be recorded. |
| Central macular thickness (CMT) | 6 months post-procedure | Central macular thickness (CMT) will be recorded. |
| Frequency distribution of Fluorescein leakage | 6 months post-procedure | Frequency distribution of Fluorescein leakage will be recorded. |
Countries
Egypt
Contacts
Primary ContactHatem F Abd Elfatah, MD
Outcome results
None listed